What is the recommended approach for adding propranolol (beta blocker) to treat akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol for Akathisia: Dosing and Implementation

For akathisia, propranolol 10 mg three times daily (TID) is an appropriate starting dose, with the option to titrate up to 30 mg TID based on response. 1

Recommended Dosing Strategy

  • Start with propranolol 10 mg TID as you've indicated, which aligns with the most recent international schizophrenia treatment guidelines 1
  • Titrate up to 30 mg TID if needed for optimal symptom control, as doses of 30-80 mg/day have demonstrated substantial improvement in akathisia 2
  • Response occurs rapidly, typically within 24 hours in most cases, so you can assess effectiveness quickly 2
  • Low doses are generally sufficient (30-80 mg/day total), with most patients responding well without requiring higher doses 2

Treatment Algorithm for Akathisia

First-line approach:

  • Attempt dose reduction of the offending antipsychotic if clinically feasible 1
  • If positive symptoms are well controlled, gradual reduction while remaining in therapeutic range should be considered 1

Second-line pharmacological intervention:

  • Propranolol is the preferred beta-blocker for akathisia treatment 1, 2
  • Alternative: Switch to quetiapine or olanzapine if antipsychotic change is appropriate 1
  • Benzodiazepines may provide relief but are not first-line 1

Critical Contraindications to Screen Before Prescribing

Absolute contraindications that must be ruled out before starting propranolol:

  • Asthma or reactive airway disease 1, 3
  • Bradycardia (heart rate <50 bpm) 1
  • Heart block (greater than first degree without pacemaker) 3
  • Decompensated heart failure or cardiogenic shock 3
  • Severe hypotension 3

Important Monitoring and Patient Counseling

Monitor for common side effects:

  • Bradycardia and hypotension (check heart rate and blood pressure) 1, 4
  • Fatigue and cold extremities 4
  • Sleep disturbances, nightmares, or mood changes (occur in 2-18.5% of patients) 4

Special precautions:

  • In diabetic patients, propranolol may mask hypoglycemia symptoms (tremor, tachycardia), so counsel patients to monitor blood glucose more carefully 3
  • Never discontinue abruptly after regular use, as rebound symptoms and acute myocardial ischemia can occur 3
  • Taper gradually if discontinuation becomes necessary 1

Evidence Supporting Beta-1 Selectivity

  • Both non-selective (propranolol) and beta-1 selective agents (betaxolol, metoprolol) are effective for akathisia 5, 6, 7
  • The mechanism appears to involve central beta-1 adrenoceptor blockade 5, 6
  • However, propranolol remains the most studied and recommended agent in current guidelines 1, 2

Common Pitfall to Avoid

Do not mistake akathisia for psychotic agitation or anxiety, as this is a frequent error that leads to inappropriate dose escalation of antipsychotics, worsening the problem 1. Akathisia presents as severe restlessness with pacing and physical agitation, and is a common reason for medication non-adherence 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Propranolol in the treatment of neuroleptic-induced akathisia.

The American journal of psychiatry, 1984

Guideline

Propranolol Indications and Usage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol and Depression: Mechanism and Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Akathisia: selective beta-blockers and rating instruments.

Psychopharmacology bulletin, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.